Newsroom

APRIL 9, 2019 Glytec Receives Another Patent Allowance for Therapy Advisor® The company is expanding its software-as-a-medical-device platform to support the optimization of ALL diabetes medications. Waltham, MA — The United States Patent and Trademark Office has granted Glytec another patent allowance for systems and methods related to a product registered under the brand name, Therapy...

JANUARY 9, 2018 USPTO Grants Glytec Patent Allowance for Computer-Guided Selection and Dosing of All Diabetes Medications The new patent allowance addresses personalized optimization of insulin and non-insulin medications alike. Waltham, MA — Long recognized as the market leader in enterprise software solutions for insulin management, Glytec is expanding its intellectual property protections...